Ross N. England, MD, PhD

Papers

2020

Kulick-Soper CV, McKee JL, Wolf RL, Mohan S, Stein JM, Masur, JH, Lazor JW, Dunlap DG, McGinniss JE, David MZ, England RN, Rothstein A, Gelfand MA, Cucchiara BL, Davis KA. Pearls and Oy-sters: Bilateral globus pallidus lesions in a patient with COVID-19. Neurology 2020; 95(10): 454-57.

England RN, Pak J, Liu M, Rao S, Azono O, Levy O, van Haren SD. The Distinct Neonatal Immune Response to Toll-like Receptor 7/8 Activation is Controlled by Plasma Factors Through the Expression of Let-7g. In Submission

2017

Gabunia K, Herman AB, Ray M, Kelemen SE, England RN, DeLa Cadena R, Foster WJ, Elliott KJ, Eguchi S, Autieri MV. Induction of MiR133a Expression by IL-19 Targets LDLRAP1 and Reduces oxLDL Uptake in VSMC. J Mol Cell Cardiol 2017; 105: 38-48.

2014

Kako F, Gabunia K, Ray M, Kelemen SE, England RN, Kako B, Scalia RG, Autieri MV. Interleukin-19 Induces Angiogenesis in the Absence of Hypoxia by Direct and Indirect Immune Mechanisms. Am J Physiol Cell Physiol 2016; 310(11): C931-41. 2014

Ellison S, Gabunia K, Richards JM, Kelemen SE, England RN, Rudic D, Azuma YT, Munroy MA, Eguchi S, Autieri MV. IL-19 Reduces Ligation-Mediated Neointimal Hyperplasia by Reducing Vascular Smooth Muscle Cell Activation. Am J Pathol 2014; 184(7): 2134-43.

2013

Ellison S, Gabunia K, Kelemen SE, England RN, Scalia R, Richards JM, Orr AW, Traylor JG Jr, Rogers T, Cornwell W, Berglund LM, Goncalves I, Gomez MF, Autieri MV. Attenuation of Experimental Atherosclerosis by Interleukin-19. Arteriorscler Thromb Vasc Biol 2013; 33(10): 2316-2324.

England RN, Preston KJ, Scalia R, Autieri MV. Interleukin-19 Decreases Leukocyte-Endothelial Cell Interactions by Reduction in Endothelial Cell Adhesion Molecule mRNA Stability. Am J Physiol Cell Physiol 2013; 305(3): C255-65.

2012

Sommerville LJ, Kelemen SE, Ellison SP, England RN, Autieri MV. Increased atherosclero- sis and vascular smooth muscle cell activation in AIF-1 transgenic mice fed a high-fat diet. Atherosclerosis 2012; 220(1): 45-52. England RN, Autieri MV. Anti-in ammatory eects of interleukin-19 in vascular disease. Int J In amm 2012; 253583.

2011

Gabunia K, Jain S, England RN, Autieri MV. Anti-in ammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility. Am J Physiol Cell Physiol 2011; 300(4): C896-906.

Posters and Presentations

2019

England RN, Liu M, Pak J, Levy O, van Haren SD. Dual TLR7/8 and Mincle Agonism in Human Newborn Dendritic Cells Induces Let-7g and miR-155 Expression. Pediatric Academic Societies 2019.

2017

England RN, Liu M, Levy O, van Haren SD. Dual Activation of Human Dendritic Cells via TLR7/8 and the C-type Lectin Receptor Mincle Induces Let-7g and miR-155 Expression. International Precision Vaccines Conference 2017.

2013

England RN, Kelemen S, Ellison S, Autieri MV. Identifying Mechanisms of Interleukin-19- Mediated HuR-Dependent Reduction in Vascular Cell mRNA Stability. FASEB J. 2013; 27: 648.5.

Ellison S, Gabunia K, Richards J, Kelemen SE, England RN, Scalia R, Orr AW, Berglund LM, Gomez MF, Autieri MV. Attenuation of Experimental Atherosclerosis by Interleukin-19. FASEB J. 2013; 27: 869.7.

2012

England RN, Kelemen SE, Preston KJ, Ellison SP, Scalia R, Autieri MV. Interleukin-19 Reduces Leukocyte-Endothelial Cell Interactions. Abstracts: Arteriosclerosis, Thrombosis, and Vascular Biology 2012 Scientic Sessions. Arterioscler Thromb Vasc Biol 2012; 52.

2011

England RN, Gabunia K, Cuneo A, Ellison S, Kelemen S, Autieri MV. IL-19 decreases ox-LDL induced VSMC activation by suppression of scavenger receptor expression and reduction of ox-LDL uptake. FASEB J. 2011;25: 39.12.

Gabunia K, Jain S, England RN, Autieri MV. The Anti-In ammatory Cytokine Interleukin-19 Inhibits Smooth Muscle Cell Migration and Activation of Cytoskeletal Regulators of VSMC Motility. FASEB J. 2011; 25:616.9.